19 December,2020 08:40 AM IST | New Delhi | IANS
This picture has been used for representational purpose
The All India Institute of Medical Sciences (AIIMS) on Friday sought a list of MBBS students, nursing students and fellows, from its various departments, who will be administered the Covid vaccines on priority basis in the first phase of the vaccination drive.
The list was sought as the Union Health Ministry is preparing a database of healthcare workers and other workers in healthcare settings who will be receiving the vaccine shot after its rollout.
The Central government plans to vaccinate nearly 30 crore people in the first phase of drive. It will be offered to one crore healthcare workers, along with two crore frontline and essential workers and 27 crore elderly, mostly above the age of 50 years with comorbidities.
The ministry has asked states and union territories to upload data of healthcare workers on its digital application - Covid-19 Vaccine Intelligence Network (COVIN).
ALSO READ
Mid-Day Top News: Maharashtra assembly polls likely only after Diwali and more
Congress: Centre insensitive to statehood restoration demand, will be poll issue
Haryana Assembly elections: Ramdas Athawale's RPI(A) seeks 2 seats from BJP
NC to prioritise lifting of AFSPA if voted to power in J-K, says Omar Abdullah
BJP may ally with regional parties, independents: Omar Abdullah
In a notice, AIIMS Registrar Sanjay Lalwani asked the chief of centres, head of departments, principal college of nursing and hostel superintendent to the send the copy of identity cards (IDs) and its numbers in excel sheet latest by December 19.
The AIIMS administration has also sought IDs of senior residents, junior residents, fellows, MBBS students, paramedical students, B.Sc. (Hons.) nursing students and B.Sc Nursing working or studying under their supervision "for onward transmission to the computer facility for receiving the Covid-19 vaccine."
India has eight Covid-19 vaccine candidates, including three indigenous vaccines, under different stages of clinical trials which could be ready for authorization in near future.
It includes Oxford university developed AstraZeneca, Serum Institute of India manufactured Covishield, Covaxin by Bharat Biotech Limited, ZyCoV-D by Zydus Cadila and Russian vaccine candidate Sputnik-V.
The list also contains NVX-CoV2373 by SII, HGCO19 by Geneva, and two unlabeled vaccines-Recombinant Protein Antigen based vaccine by Biological E Limited-and Inactivated rabies vector platform by Bharat Biotech.
Catch up on all the latest Mumbai news, crime news, current affairs, and a complete guide from food to things to do and events across Mumbai. Also download the new mid-day Android and iOS apps to get latest updates.
Mid-Day is now on Telegram. Click here to join our channel (@middayinfomedialtd) and stay updated with the latest news
This story has been sourced from a third party syndicated feed, agencies. Mid-day accepts no responsibility or liability for its dependability, trustworthiness, reliability and data of the text. Mid-day management/mid-day.com reserves the sole right to alter, delete or remove (without notice) the content in its absolute discretion for any reason whatsoever
